Triethylamine → HCID 11989988, compound
Reaction equation
[C:1]([NH:4][C:5]1[S:6][C:7]([C:11]2[N:12]=[C:13]([C:16](Cl)=[O:17])[S:14][CH:15]=2)=[C:8]([CH3:10])[N:9]=1)(=[O:3])[CH3:2].CC1(C)[O:24][CH:23]([CH2:25][NH2:26])[CH2:22][O:21]1.C(N(CC)CC)C>C1COCC1.C(Cl)Cl>[C:1]([NH:4][C:5]1[S:6][C:7]([C:11]2[N:12]=[C:13]([C:16]([NH:26][CH2:25][CH:23]([OH:24])[CH2:22][OH:21])=[O:17])[S:14][CH:15]=2)=[C:8]([CH3:10])[N:9]=1)(=[O:3])[CH3:2]Participants
Procedure
2′-Acetylamino-4′-methyl-[4,5′]bithiazolyl-2-carbonyl chloride, prepared as in Step I of Example 13, described above, (160 mg; 0.53 mmol; 1 eq.), is dissolved in THF (8 ml) and DCM (4 ml). 2,2-Dimethyl-1,3-dioxolane-4-methanamine (Aldrich) (0.07 ml; 0.53 mmol; 1 eq.) and triethylamine (0.15 ml; 1.06 mmol; 2 eq.) are added and the mixture is stirred overnight at rt. Solvents are evaporated and the crude product is purified by preparative HPLC. As some TFA is used for the mobile phase of the preparative HPLC, the diol protecting group is removed during the concentration of the chromatography fractions, affording directly Compound (39) as a white-off solid (26.6 mg; 14%). 1H NMR (DMSO-d6, 300 MHz) δ 2.15 (s, 3H), 2.49 (s, 3H), 3.17-3.52 (m, 4H), 3.67 (m, 1H), 4.65 (br s, 1H), 4.93 (br s, 1H), 7.99 (s, 1H), 8.46 (t, J=4.5 Hz, 1H), 12.15 (s, 1H). M− (ESI): 355.04; M+ (ESI): 356.99. HPLC (method A), Rt: 1.87 min (purity: 100%).
Workup
- customSolvents are evaporated
- customthe crude product is purified by preparative HPLC
- customthe diol protecting group is removed during the concentration of the chromatography fractions
Sources & evidence
- ORD record
- ord-c7608301daba485ba3f373804e8ac739
- Source dataset
- uspto-grants-2010_09
- Patent number
- US07799814B2
Reaction notes
Loading…